123 related articles for article (PubMed ID: 6141909)
21. Peroxidation of the antimalarial drug primaquine: characterization of a benzidine-like metabolite with methaemoglobin-forming activity.
Morais Mda S; Augusto O
Xenobiotica; 1993 Feb; 23(2):133-9. PubMed ID: 8498077
[TBL] [Abstract][Full Text] [Related]
22. Enantioselective analysis of primaquine and its metabolite carboxyprimaquine by capillary electrophoresis.
Bortocan R; Bonato PS
Electrophoresis; 2004 Aug; 25(16):2848-53. PubMed ID: 15352018
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes.
Allahyari R; Strother A; Fraser IM; Verbiscar AJ
J Med Chem; 1984 Mar; 27(3):407-10. PubMed ID: 6699888
[TBL] [Abstract][Full Text] [Related]
24. Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling.
Avula B; Tekwani BL; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan SI; Adelli VR; Sahu R; Elsohly MA; McChesney JD; Khan IA; Walker LA
J Mass Spectrom; 2013 Feb; 48(2):276-85. PubMed ID: 23378100
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes.
Shoemaker DD; Cysyk RL; Gormley PE; DeSouza JJ; Malspeis L
Cancer Res; 1984 May; 44(5):1939-45. PubMed ID: 6546898
[TBL] [Abstract][Full Text] [Related]
26. An improved pharmacodynamic model for formation of methemoglobin by antimalarial drugs.
Fasanmade AA; Jusko WJ
Drug Metab Dispos; 1995 May; 23(5):573-6. PubMed ID: 7587933
[TBL] [Abstract][Full Text] [Related]
27. Oxidative activity of primaquine metabolites on rat erythrocytes in vitro and in vivo.
Vásquez-Vivar J; Augusto O
Biochem Pharmacol; 1994 Jan; 47(2):309-16. PubMed ID: 8304975
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
Avula B; Tekwani BL; Chaurasiya ND; Fasinu P; Dhammika Nanayakkara NP; Bhandara Herath HMT; Wang YH; Bae JY; Khan SI; Elsohly MA; McChesney JD; Zimmerman PA; Khan IA; Walker LA
Malar J; 2018 Aug; 17(1):294. PubMed ID: 30103751
[TBL] [Abstract][Full Text] [Related]
29. Two mechanisms for toxic effects of hydroxylamines in human erythrocytes: involvement of free radicals and risk of potentiation.
Evelo CT; Spooren AA; Bisschops RA; Baars LG; Neis JM
Blood Cells Mol Dis; 1998 Sep; 24(3):280-95. PubMed ID: 10087986
[TBL] [Abstract][Full Text] [Related]
30. Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro.
Baird JK; McCormick GJ; Canfield CJ
Biochem Pharmacol; 1986 Apr; 35(7):1099-106. PubMed ID: 3754446
[TBL] [Abstract][Full Text] [Related]
31. In vitro metabolism of a potent HIV-protease inhibitor (141W94) using rat, monkey and human liver S9.
Singh R; Chang SY; Taylor LC
Rapid Commun Mass Spectrom; 1996; 10(9):1019-26. PubMed ID: 8755234
[TBL] [Abstract][Full Text] [Related]
32. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment.
Carmona-Fonseca J; Alvarez G; Maestre A
Am J Trop Med Hyg; 2009 Feb; 80(2):188-93. PubMed ID: 19190211
[TBL] [Abstract][Full Text] [Related]
33. Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity.
Jain M; Vangapandu S; Sachdeva S; Singh S; Singh PP; Jena GB; Tikoo K; Ramarao P; Kaul CL; Jain R
J Med Chem; 2004 Jan; 47(2):285-7. PubMed ID: 14711300
[TBL] [Abstract][Full Text] [Related]
34. Enantioselective metabolism of primaquine by human CYP2D6.
Fasinu PS; Tekwani BL; Nanayakkara NP; Avula B; Herath HM; Wang YH; Adelli VR; Elsohly MA; Khan SI; Khan IA; Pybus BS; Marcsisin SR; Reichard GA; McChesney JD; Walker LA
Malar J; 2014 Dec; 13():507. PubMed ID: 25518709
[TBL] [Abstract][Full Text] [Related]
35. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
Prakash C; Wang W; O'Connell T; Johnson KA
Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
[TBL] [Abstract][Full Text] [Related]
37. Production of a novel dimeric metabolite of primaquine by Streptomyces rimosus.
Clark AM; Hufford CD; Puri RK; McChesney JD
Appl Environ Microbiol; 1984 Mar; 47(3):540-3. PubMed ID: 6712222
[TBL] [Abstract][Full Text] [Related]
38. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
[TBL] [Abstract][Full Text] [Related]
39. In vitro metabolism of the HIV-1 protease inhibitor ABT-378: species comparison and metabolite identification.
Kumar GN; Jayanti V; Lee RD; Whittern DN; Uchic J; Thomas S; Johnson P; Grabowski B; Sham H; Betebenner D; Kempf DJ; Denissen JF
Drug Metab Dispos; 1999 Jan; 27(1):86-91. PubMed ID: 9884314
[TBL] [Abstract][Full Text] [Related]
40. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy.
Dierling AM; Cui Z
Int J Pharm; 2005 Oct; 303(1-2):143-52. PubMed ID: 16140485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
